Dermatar

Italy
Brand name Dermatar
Form ointment
Active substance / Dosage
BETAMETHASONE
Prescription type Prescription only
ATC code
D07XC01
Registration number 024073
Manufacturer IDI FARMACEUTICI S.R.L.
Dermatar ointment

Table of Contents

Package leaflet: Information for the user

DERMATAR 15mg/g + 15mg/g + 0.5mg/g

Salicylic acid/Ammonium sulfotiolate/Betamethasone 17-valerate 21-acetate
Please read this leaflet carefully before using this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not give it to others, even if they have the same symptoms as yours, because it may be harmful.
  • If any adverse reaction occurs, including those not listed in this leaflet, contact your doctor or pharmacist. See section 4.

Contents of this leaflet:

  1. What DERMATAR is and what it is used for
  2. What you need to know before using DERMATAR
  3. How to use DERMATAR
  4. Possible side effects
  5. How to store DERMATAR
  6. Contents of the pack and other information

1. What DERMATAR is and what it is used for

DERMATAR contains the active substances Salicylic acid, Ammonium thiosalicylate, and Betamethasone 17-valerate 21-acetate, and belongs to the category of topical corticosteroid medications with antiseptics.
DERMATAR is indicated for the treatment of subacute, chronic, lichenified eczema, lichen simplex chronicus, psoriasis in acute exacerbation phase, and all dermatoses with infiltrative and chronic components.

2. What you need to know before using DERMATAR

Do not use DERMATAR

  • If you are allergic to Salicylic Acid, Ammonium Sulfidothiolate, Betamethasone 17-valerate 21-acetate, or any of the other ingredients of this medicine (listed in section 6).
  • If you suffer from cutaneous tuberculosis (cutaneous TB).
  • If you suffer from herpes simplex.
  • If you have viral diseases affecting the skin.

Warnings and precautions
Talk to your doctor or pharmacist before using DERMATAR.
Topical application of corticosteroids for the treatment of extensive dermatoses or over prolonged periods may result in absorption through the skin into the bloodstream (systemic absorption); this is more likely to occur when treating skin folds or when using occlusive dressings.
In infants, diapers may act as occlusive dressings (non-breathable).
DERMATAR must not be applied to mucous membranes, eyes, lips, or nostrils.
The use of DERMATAR, especially if prolonged, may lead to sensitization reactions. If this occurs, stop treatment and consult your doctor to determine appropriate therapy.
The use of DERMATAR may cause photosensitization reactions. Consult your doctor before exposing treated lesions to light.
Contact your doctor if you experience blurred vision or other visual disturbances.
Caution for athletes: This product contains substances prohibited in doping. Any use differing from the therapeutic indications, dosage regimen, or route of administration specified is forbidden.

Children
In infants, diapers may act as occlusive dressings.
Use DERMATAR in early infancy only when strictly necessary and under direct medical supervision.

Other medicines and DERMATAR
Inform your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
No interactions with other medicines are known.

Pregnancy and breastfeeding
If you are pregnant, think you may be pregnant, planning a pregnancy, or breastfeeding, consult your doctor or pharmacist before using this medicine.
Use DERMATAR during pregnancy and breastfeeding only when strictly necessary and under direct medical supervision.

Driving and using machines
No effects on the ability to drive or operate machinery.

DERMATAR contains:

  • Lanolin alcohols, which may cause local skin reactions (e.g., contact dermatitis).
  • Butylated hydroxyanisole, which may cause localized skin reactions (e.g., contact dermatitis) or irritation to eyes and mucous membranes.

3. How to use DERMATAR

Use this medicine exactly as directed by your doctor or pharmacist. If you have any doubts, consult your
doctor or pharmacist.
DERMATAR is for external use only.
Apply DERMATAR to the affected area with gentle, penetrating massage, in a non-excessive amount one or
two times daily.
Before reapplying, remove any residue with a swab soaked in olive oil.
If you have any doubts about how to use this medicine, consult your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone experiences them.
Prolonged treatment with corticosteroids may cause the following effects:

  • Hypopigmentation (reduction in normal skin colour);
  • Hypertrichosis (excessive hair growth);
  • Acneiform eruptions (appearance of pustules);
  • Folliculitis (inflammation of the hair follicle).

With prolonged use of occlusive dressings, the following may occur:

  • Cutaneous atrophy (loss of skin thickness and elasticity);
  • Maceration;
  • Striae (stretch marks);
  • Secondary infections.

Ammonium sulfosuccinate may cause photosensitization reactions.
If any of these effects occur, discontinue treatment and initiate appropriate therapies.
Blurred vision may occur with unknown frequency (frequency cannot be estimated based on available data).

Reporting of side effects
If you experience any side effect, including those not listed in this leaflet, talk to your doctor or pharmacist.
You can also report side effects directly via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse .
By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store DERMATAR

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging.
The expiry date refers to the last day of that month.
Do not dispose of any medicine via wastewater or household waste. Ask your pharmacist how to dispose of
medicines you no longer use. This will help protect the environment.

6. Contents of the pack and other information

What DERMATAR contains

  • The active substances are: salicylic acid, ammonium sulfotiolate and betamethasone 17-valerate 21-acetate. Each 1 g of ointment contains 15 mg of salicylic acid, 15 mg of ammonium sulfotiolate and 0.5 mg of betamethasone 17-valerate 21-acetate.
  • The other components are: Vaseline oil, Lanolin alcohols, Isopropyl lanolate, Polyethylene glycol monostearate, Butylhydroxyanisole, Vaseline.

Description of the appearance of DERMATAR and contents of the pack
Pack containing one tube of 30 g of ointment.
Marketing Authorization Holder and Manufacturer
IDI FARMACEUTICI S.r.l. - Via dei Castelli Romani 83/85 - 00071 - Pomezia (RM)
March 2026
By scanning the QR Code or visiting the website http://www.leafletidi.it/dermatar, it is possible to read or listen to
this package leaflet.

Square QR code composed of a pattern of small black square modules on a white background for digital scanning of information